文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肝硬化患者的细菌易位:生理学、临床后果及实际意义。

Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.

机构信息

a Internal Medicine, Gastroenterology and Hepatology , Fondazione Agostino Gemelli Hospital , Rome , Italy.

出版信息

Expert Rev Gastroenterol Hepatol. 2018 Jul;12(7):641-656. doi: 10.1080/17474124.2018.1481747. Epub 2018 Jun 6.


DOI:10.1080/17474124.2018.1481747
PMID:29806487
Abstract

The gut liver axis is an operative unit that works to protect the human body against potentially harmful substances and microorganisms, maintaining the homeostasis of the immune system. Liver cirrhosis profoundly alters this complex system. The intestine becomes more permeable allowing the translocation of bacteria, bacterial products and fragments into the portal circulation, triggering an abnormal local and systemic inflammatory response and a condition of perpetual immunologic alarm. This immune-inflammatory disorder related to dysbiosis is involved in the development of liver damage and liver cirrhosis complications and increases intestinal permeability in a vicious circle. Areas covered: The most relevant studies on bacterial translocation, the mechanism of intestinal barrier dysfunction and its consequences in patients with liver cirrhosis have been revised through a PubMed search. Data have been discussed with particular regard to their significance in clinical practice. Expert commentary: The assessment of bacterial translocation and intestinal permeability is not currently used in clinical practice but may be useful to stratify patients' prognosis.

摘要

肠肝轴是一个作用单位,它可以保护人体免受潜在的有害物质和微生物的侵害,维持免疫系统的内稳态。肝硬化会深刻改变这个复杂的系统。肠道变得更加通透,允许细菌、细菌产物和碎片移位到门静脉循环中,引发异常的局部和全身炎症反应和持续的免疫警报。这种与菌群失调相关的免疫炎症紊乱与肝损伤和肝硬化并发症的发展有关,并在恶性循环中增加肠道通透性。涵盖领域:通过 PubMed 检索,对与细菌易位、肠道屏障功能障碍机制及其在肝硬化患者中的后果相关的最相关研究进行了综述。特别关注了它们在临床实践中的意义。专家评论:细菌易位和肠道通透性的评估目前尚未在临床实践中使用,但可能有助于对患者的预后进行分层。

相似文献

[1]
Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.

Expert Rev Gastroenterol Hepatol. 2018-6-6

[2]
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

World J Gastroenterol. 2014-12-7

[3]
Gut microbiota-related complications in cirrhosis.

World J Gastroenterol. 2014-11-14

[4]
Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.

World J Gastroenterol. 2016-3-14

[5]
Gut microbiota and host metabolism in liver cirrhosis.

World J Gastroenterol. 2015-11-7

[6]
The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.

Transplantation. 2016-1

[7]
Clinical impact of microbiome in patients with decompensated cirrhosis.

World J Gastroenterol. 2018-9-14

[8]
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.

Hepatol Int. 2017-5-26

[9]
Inflammatory status in human hepatic cirrhosis.

World J Gastroenterol. 2015-11-7

[10]
Alcoholic liver disease: the gut microbiome and liver cross talk.

Alcohol Clin Exp Res. 2015-5

引用本文的文献

[1]
Use of Terlipressin in Liver Transplant Candidates.

Gastroenterol Hepatol (N Y). 2025-8

[2]
The role of cyclic di-GMP in biomaterial-associated infections caused by commensal Escherichia coli.

PLoS One. 2025-8-20

[3]
A new insight: crosstalk between neutrophil extracellular traps and the gut-liver axis for nonalcoholic fatty liver disease.

Front Immunol. 2025-6-27

[4]
Analysis of gut and circulating microbiota characteristics in patients with liver cirrhosis and portal vein thrombosis.

Front Microbiol. 2025-6-19

[5]
Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management.

Metabolites. 2025-2-13

[6]
"Pleiotropic" Effects of Antibiotics: New Modulators in Human Diseases.

Antibiotics (Basel). 2024-12-4

[7]
Intestinal permeability disturbances: causes, diseases and therapy.

Clin Exp Med. 2024-9-28

[8]
Therapeutic effect of fecal microbiota transplantation on rats with liver cirrhosis and its influence on gut microbiota.

Iran J Basic Med Sci. 2024

[9]
Lifestyle Changes and Industrialization in the Development of Allergic Diseases.

Curr Allergy Asthma Rep. 2024-7

[10]
Therapeutic Potential of Fucoidan in Alleviating Histamine-Induced Liver Injury: Insights from Mice Studies.

Foods. 2024-5-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索